Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial
Petr Widimský, Stuart J. Connolly, Quilong Yi, Olga Shestakovska, Salim Yusuf, John W. Eikelboom, Kelley R. Branch, Jeffrey L. Probstfield, Jackie Bosch, Deepak L. Bhatt, Aldo Maggioni, Eva Muehlhofer, Álvaro Avezum (2023). Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial. , 258, DOI: https://doi.org/10.1016/j.ahj.2023.01.008.
